Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Product categories
Product categories
Medicine
Products 1 to 10 of 13
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
ActoBiotics: AG013 (Oral Mucositis)
by
Actobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (5 years ago)
Date last modified:
2019/09/12 15:12 (5 years ago)
Known funding amount:
N/A
Funding types:
Government
+
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Personal Care (Topical)
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
ActoBiotics: AG019 (Type 1 Diabetes)
by
Actobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (5 years ago)
Date last modified:
2019/09/12 15:12 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Bacterial toxin promoting tissue healing
by
Friedrich Schiller University Jena
Biotech components:
Bacteria
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (4 years ago)
Date last modified:
2020/12/18 14:39 (4 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
Bioengineered Salmonella enterica
by
Prokarium
Biotech components:
Microbe
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (5 years ago)
Date last modified:
2019/09/12 15:18 (5 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
COVID-19 Antibody Treatment
by
Adagio
Biotech components:
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (4 years ago)
Date last modified:
2020/12/18 14:39 (4 years ago)
Known funding amount:
50,000,000 USD
Funding types:
Private Funding
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
crPhage
by
Locus Biosciences
Biotech components:
Gene Editing
+
Molecule
+
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:10 (5 years ago)
Date last modified:
2019/09/12 15:10 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Health
+
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
GM Yeast to make Cannabis
by
University of California, Berkeley
+
Demetrix Inc.
Biotech components:
Yeast
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (5 years ago)
Date last modified:
2019/09/12 15:18 (5 years ago)
Known funding amount:
11,000,000 USD
Funding types:
Venture Capital
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
+
University
Product categories:
Medicine
Production process:
N/A
Source:
Scientist Magazine
Trading symbol:
N/A
Value chain stage:
Input
MG53 (natural human protein) (preventing lethal lung damage from the flu)
by
Ohio State University
Biotech components:
Molecule
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (4 years ago)
Date last modified:
2020/12/18 14:39 (4 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medicine
+
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
OG716: Lantibiotics
by
Oakbio
+
Oragenics
Biotech components:
Molecule
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (5 years ago)
Date last modified:
2019/09/12 15:16 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Sleeping Beauty
by
Ziophram
Biotech components:
Virus
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
182,600,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medicine
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
ZIOP
(NASDAQ)
Value chain stage:
Finished Product
1
2
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
